| SC 13G/A | 2024-02-27 | Patient Capital Management, LLC | PRECIGEN, INC. | 15,983,700 | 6.4% | EDGAR |
| SC 13G/A | 2024-02-14 | Ares Trading S.A. | PRECIGEN, INC. | 20,647,152 | 8.3% | EDGAR |
| SC 13G | 2024-02-14 | Patient Capital Management, LLC | PRECIGEN, INC. | 15,983,700 | 6.4% | EDGAR |
| SC 13D/A | 2023-01-31 | KIRK RANDAL J | PRECIGEN, INC. | 96,360,443 | 38.3% | EDGAR |
| SC 13G/A | 2023-01-27 | Ares Trading S.A. | PRECIGEN, INC. | 20,647,152 | 9.9% | EDGAR |
| SC 13D/A | 2022-10-07 | KIRK RANDAL J | PRECIGEN, INC. | 84,805,277 | 40.7% | EDGAR |
| SC 13G/A | 2022-01-24 | Ares Trading S.A. | PRECIGEN, INC. | 20,647,152 | 10.0% | EDGAR |
| SC 13G/A | 2021-02-16 | MILLER VALUE PARTNERS, LLC | PRECIGEN, INC. | 7,134,094 | 3.8% | EDGAR |
| SC 13G/A | 2021-01-08 | Ares Trading S.A. | PRECIGEN, INC. | 27,398,519 | 14.8% | EDGAR |
| SC 13D/A | 2020-12-21 | KIRK RANDAL J | PRECIGEN, INC. | 81,822,163 | 43.6% | EDGAR |
| SC 13D/A | 2020-08-13 | KIRK RANDAL J | PRECIGEN, INC. | 84,000,000 | 48.7% | EDGAR |
| SC 13G | 2020-02-14 | MILLER VALUE PARTNERS, LLC | PRECIGEN, INC. | 8,416,710 | 5.2% | EDGAR |
| SC 13D/A | 2020-02-04 | KIRK RANDAL J | PRECIGEN, INC. | 81,523,936 | 48.2% | EDGAR |
| SC 13G/A | 2020-01-22 | Ares Trading S.A. | INTREXON CORP | 24,852,348 | 14.9% | EDGAR |
| SC 13D/A | 2020-01-06 | KIRK RANDAL J | INTREXON CORP | - | - | EDGAR |
| SC 13D/A | 2019-06-10 | KIRK RANDAL J | INTREXON CORP | 74,378,292 | 46.1% | EDGAR |
| SC 13D/A | 2019-05-28 | KIRK RANDAL J | INTREXON CORP | 72,179,353 | 44.8% | EDGAR |
| SC 13D/A | 2019-05-15 | KIRK RANDAL J | INTREXON CORP | 70,439,882 | 43.7% | EDGAR |
| SC 13G | 2019-01-07 | Ares Trading S.A. | INTREXON CORP | 24,080,139 | 14.7% | EDGAR |
| SC 13D/A | 2018-07-06 | KIRK RANDAL J | INTREXON CORP | 66,789,237 | 48.8% | EDGAR |